Table 1:

Clinical studies included in this review

Reference No.Number of PatientsSuccessful OutcomeComplicationsNature of TrialFollow-up (months)
n%CI (%)n%
826207759–9500Case series?
91691287670–8221.2Case series19 (mean)
10768660–100112.5Case series3–4
1163447259–8511.8Case control20–45
123502657672–8050.97Case series84 (mean)
131496433–9500Case series6
1482577058–8200Case series12–24
1546316750–8400Case series2–21
1650377460–8848Case series24–60
1799868780–9400Case series24
181971477569–8110.51Case seriesMax. 44
191471157871–8510.6Case seriesMax. 60
2035329283–10012.8Case series18
2116486**149.6Case seriesAt least 12
2540348573–9700Case series18
2790667363–8400Case series12–23
  • * In this trial, each patient was assigned to 1 of 3 groups: 1) those who met all selection criteria for PLDD (leg pain, positive physical examination finding such motor, sensory, or reflex deficits, and/or straight leg raise, contained disk herniation confirmed by diskography); 2) those who did not meet the selection criteria (had a normal physical examination, the presence of stenosis, spondylolisthesis, extruded disk fragment, leakage of diskographic dye from the outer annulus, multiple prior lumbar surgeries; or 3) those who could not be assigned to either of the first 2 groups for reasons such as diskography not being performed or inadequate physical examination data recorded in the chart. In group 1, 29 of 41 patients (70.7%; CI, 57%–85%) had successful outcomes. In group 2, 12 of 42 patients (29%; CI, 12%–42%) had successful outcomes. In group 3, 45 of 81 patients (56%; CI, 45%–66%) had successful outcomes. In group 4, 20 of 45 patients (44%; CI, 30%–59%) had successful outcomes.